The South America Cath Lab Services Market is expected to reach a market size of more than USD 1.33 Billion by 2031.
The South American Cath Lab Services market is a vital and rapidly evolving segment of the region’s healthcare landscape, driven by a significant and growing burden of cardiovascular diseases and a strong shift toward advanced, minimally invasive procedures. The regulatory environment is complex, anchored primarily by ANVISA in Brazil, which enforces Resolution (RDC) 751/2022 requiring all medical devices to be classified by risk and obtain market authorization, with Class III and IV devices needing a full registration pathway including BGMP certification. In Argentina, ANMAT has introduced major reforms Disposición 8799/2025 established a simplified, fast-track approval process for low-risk Class I and II devices via an online sworn declaration, while Decreto 892/2025 allows automatic recognition of products already certified in reference countries like the EU and USA, eliminating duplicate testing. The most significant opportunity lies in the anticipated arrival of Pulsed Field Ablation for cardiac arrhythmia treatment, which offers a revolutionary non-thermal and safer alternative to existing modalities, though its adoption will be phased. A notable global example that influences the region is Medtronic’s agreement in February 2026 to acquire digital health company CathWorks for up to $585 million, a move specifically aimed at expanding its physiology-driven diagnostic tools within cath labs, a trend that directly impacts the high-tech services offered across South American facilities. In Brazil, local distributors are attracting global attention, with SMT LATAM’s acquisition of Zarek Distribuidora De Produtos Hospitalares strengthening its access to the interventional cardiology market. According to the research report, "South America Cath Lab Services Market Outlook, 2031," published by Bonafide Research, the South America Cath Lab Services Market is expected to reach a market size of more than USD 1.33 Billion by 2031. A landmark medical event was the 80th Brazilian Congress of Cardiology in São Paulo in September 2025, which was the largest cardiology meeting in Latin America, attracting nearly 9,000 participants and serving as a major platform for unveiling new cath lab technologies and interventional techniques. In a major technological leap, XCath successfully completed the world’s first telerobotic mechanical thrombectomy for stroke in Panama in March 2026, operating a patient over 200 kilometers away, demonstrating the immense potential for remote robotic interventions to expand access to critical care in underserved regions. Brazilian research is also at the forefront, with a multicenter registry of Pulsed Field Catheter Ablation published in February 2026 highlighting its rapid adoption, high acute efficacy, and short learning curve for treating atrial fibrillation within the country. The commitment of major players is evident through strategic partnerships, such as the 2026 launch of an AI-powered intravascular ultrasound platform by Boston Scientific at Hospital São Lucas in Brazil, the collaboration between Philips and Hospital Einstein to develop a Large Language Model for predicting coronary artery disease from exam reports and Siemens Healthineers strengthening its regional footprint by forming a distribution partnership with Grupo Elfa in Brazil to expand access to its AI-enabled ultrasound systems.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Service Type | Diagnostic Services | |
| Therapeutic Services | ||
| By End User | Hospitals | |
| Specialty Cardiac Clinics | ||
| Ambulatory Surgical Centers | ||
| Others (Clinics, Mobile Labs) | ||
| By Appication | Cardiovascular / Cardiac | |
| Peripheral Vascular | ||
| Brain & Spine / Neuro | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
The leading growth of therapeutic services in the South America cath lab services market is driven by the increasing shift toward minimally invasive interventional cardiology procedures to manage the rising burden of cardiovascular diseases across the region. The expansion of therapeutic services in South America’s cath lab environment is strongly influenced by the growing clinical need to address cardiovascular diseases that continue to be among the most common causes of illness and mortality in the region. Countries such as Brazil, Argentina, Chile, and Colombia are witnessing a steady increase in risk factors including hypertension, diabetes, obesity, and smoking-related complications, which contribute to higher incidence of coronary artery disease and acute cardiac events. This has led healthcare providers to rely more heavily on catheter-based interventions that can directly treat blocked or narrowed arteries, restore blood flow, and stabilize patients in emergency situations. The increasing adoption of procedures such as percutaneous coronary intervention, balloon angioplasty, and stent implantation reflects a broader shift in clinical practice from diagnostic-only catheterization toward active therapeutic intervention. Improvements in hospital infrastructure, particularly in urban tertiary care centers, have enabled the establishment of modern cath labs equipped with advanced imaging systems and interventional tools, allowing physicians to perform more complex procedures with greater safety and accuracy. At the same time, growing physician expertise in interventional cardiology, supported by training programs and international collaborations, has accelerated the adoption of newer therapeutic techniques across the region. Public and private healthcare investments have also contributed to expanding access to cardiac care, enabling more patients to receive timely interventional treatment rather than relying solely on medical management. Ambulatory surgical centers are the fastest-growing end user segment in the South America cath lab services market due to the increasing shift toward cost-efficient, minimally invasive cardiac procedures that allow same-day diagnosis and treatment outside traditional hospital settings. The growing importance of ambulatory surgical centers in South America’s cath lab services landscape is closely connected to broader healthcare system challenges, including hospital overcrowding, uneven access to specialized cardiac care, and the need for more efficient use of limited healthcare resources. In many countries across the region, large public hospitals often face high patient volumes, which create delays in elective cardiovascular procedures and increases pressure on inpatient facilities. As a result, healthcare providers are increasingly shifting suitable cardiac cases to ambulatory surgical centers where diagnostic and interventional procedures can be performed in a controlled environment without requiring overnight hospitalization. This model is particularly effective for low to moderate complexity procedures such as diagnostic coronary angiography and selected percutaneous coronary interventions, which have become safer due to advancements in catheter-based technologies and improved peri-procedural care. The adoption of modern cath lab equipment in outpatient settings has made it possible for these centers to deliver hospital-level cardiac care with reduced operational costs and faster patient turnover. In addition, rising awareness among patients regarding the benefits of minimally invasive procedures, including shorter recovery periods, reduced risk of hospital-acquired infections, and greater convenience, has contributed to increasing preference for ambulatory care settings. Cardiovascular or cardiac applications lead the South America cath lab services market because the region faces a consistently high burden of coronary artery disease and related heart conditions that require frequent diagnostic and interventional catheter-based procedures. The dominance of cardiovascular and cardiac applications in South America’s cath lab services market is closely tied to the significant and persistent impact of heart diseases on public health across the region. Countries such as Brazil, Argentina, Colombia, and Chile experience high rates of coronary artery disease, hypertension-related complications, and acute myocardial infarctions, largely influenced by lifestyle factors such as poor dietary habits, physical inactivity, smoking, and rising prevalence of diabetes and obesity. These conditions contribute to a continuous need for both emergency and elective cardiac interventions, many of which are performed in catheterization laboratories. Cath labs play a central role in the diagnosis and treatment of coronary blockages through procedures like angiography and percutaneous coronary intervention, which are widely used to restore blood flow and prevent severe cardiac damage. In emergency situations such as heart attacks, rapid access to cath lab-based treatment is critical, making cardiovascular applications the most frequently utilized service category. The expansion of hospital infrastructure in major urban centers has further supported the availability of interventional cardiology services, allowing more patients to access timely treatment. At the same time, gradual improvements in healthcare funding and insurance coverage in parts of South America have increased patient access to advanced cardiac procedures that were previously limited to private healthcare settings.
to Download this information in a PDF
Colombia is the fastest-growing market in South America’s cath lab services sector due to its rapid improvement in cardiovascular care infrastructure combined with expanding access to minimally invasive interventional cardiology procedures across both public and private healthcare systems. The strong momentum of cath lab services in Colombia is primarily driven by the country’s focused efforts to strengthen its healthcare system and improve access to advanced cardiac care in response to a growing burden of cardiovascular diseases. Conditions such as coronary artery disease, hypertension, and acute myocardial infarction have become increasingly prevalent due to changes in lifestyle patterns, urbanization, dietary shifts, and rising rates of diabetes and obesity. These health challenges have created a sustained demand for timely and effective cardiac interventions, particularly those performed in catheterization laboratories. Over the past several years, Colombia has made notable progress in expanding and modernizing its hospital infrastructure, especially in major cities such as Bogotá, Medellín, and Cali, where advanced cardiac centers are being equipped with modern cath lab technologies. This expansion has significantly improved the country’s ability to perform complex diagnostic and therapeutic procedures such as coronary angiography, percutaneous coronary intervention, and structural heart interventions. In addition, Colombia’s healthcare system, which combines public insurance coverage with a growing private healthcare sector, has improved patient access to specialized cardiac services, allowing more individuals to receive interventional treatments that were previously limited to higher-income groups or large tertiary hospitals. The increasing number of trained interventional cardiologists, supported by medical education programs and international collaborations, has further strengthened procedural capabilities and adoption of modern techniques.
to Download this information in a PDF

We are friendly and approachable, give us a call.